Introduction
Squalene epoxidase (EC 1.14.99.7, squalene monooxygenase) occupies a key position in the biosynthetic pathway leading to ergosterol. The 2,3-oxidation of the 30-carbon hydrocarbon chain of squalene is essential for subsequent cyclization to the characteristic rigid 4-ring sterol skeleton which is required for membrane function in virtually all fungi. Squalene is the first lipophilic intermediate in the sterol pathway, and the epoxidase is the first enzyme in the pathway requiring molecular oxygen. The enzymology of fungal and mammalian squalene epoxidases has recently been reviewed [ l ] . There is evidence that squalene epoxidase is an important point of regulation in mammalian cholesterol biosynthesis, and this may also be the case in fungi, although much less is currently known about regulation of fungal sterol biosynthesis.
The first specific inhibitor of squalene epoxidase to be identified was naftifine [2. 31, an antifungal agent of the allylamine class which is used clinically for topical therapy of superficial mycoses. The related compound terbinafine (an orally active clinical antimycotic) was subsequently found to be a more potent inhibitor of fungal squalene epoxidase [4, 51. The biological and clinical activities of these drugs are dealt with in detail in a recent review [6]. More than one thousand structural analogues of the allylamine type have been synthesized, many of them having antifungal activity [7-lo] . A number of these have also been shown to inhibit squalene epoxidase.
This report reviews the current state of knowledge concerning the inhibition of squalene epoxidase by allylamines in fungal and mammalian systems, together with a discussion of the mechanisms by which enzyme inhibition is translated into antifungal action.
Inhibition of fungal squalene epoxidase
Squalene epoxidase has been investigated in several yeast-like fungi and has a number of features in common with the enzyme from rat liver [ 1 1, which is the only enzyme of this type reported to have been purified [ 111. The membrane-bound (microsomal) enzyme requires molecular oxygen, NAD(P)€I and FAD for activity. In contrast to the rat liver enzyme, no soluble cytoplasmic factors are required by the fungal epoxidase. Squalene epoxidase is clearly not of the cytochrome 1'-450 superfamily as it does not contain haem and is unaffected by carbon monoxide and other known cytochrome P-450 inhibitors.
The inhibitory effects of the allylamines have primarily been investigated using the niicrosomal squalene epoxidase system which was characterized in Cundida ulbicuns [S, 121. I h t h naftifine and terbinafine cause a concentration-dependent inhibition of the C ulbicuns epoxidase, complete suppression of activity being attainable at relatively low inhibitor concentrations. Kinetic analysis of inhibition at various squalene concentrations provided evidence for a non-competitive type interaction. The K , values for naftifine and terbinafine in this system are 1.1 , UUU and 0.03 ,UV respectively. It should of course be noted that classical kinetics do not strictly apply to a heterogeneous enzyme system with an insoluble substrate such as squalene. A non-competitive inhiVolume 19 bition is. however, compatible with the observation that high levels of squalene accumulate in allylamine-treated fungi without release of the cells from the drug-induced growth inhibition. The co-factors NADH, NADPH, and FAD, as well as the soluble cytoplasmic fraction, are also completely noncompetitive with respect to inhibition by naftifine and terbinafine. The inhibition is not time-dependent and is fully reversible. Qualitatively similar results have also been obtained using a microsomal squalene epoxidase system from C parupsilosk. The enzyme from C albicans can be solubilized by detergent action and remains equally sensitive to inhibition by terbinafine [ 131, indicating that the action of the drugs is not dependent on intact membrane structure.
A number of structurally related compounds have been found to inhibit the C albicans squalene epoxidase in a manner similar to that of naftifine and terbinafine. Considerable structural variation is permitted while retaining potent epoxidase inhibition. Compounds with activity comparable with that of terbinafine include the chlorobenzthiophene SDZ 87-469 and the benzylamine derivative butenafine (structures shown in Fig. 1 ). Although the allylamine group was originally the characteristic chemical feature of these compounds, more recently it has become apparent that neither the nitrogen nor the double bond are actually required for epoxidase The discovery of the mechanism of action of the allylamines stimulated a search for further inhibitors of squalene epoxidase. At high concentrations (0.1-1.0 mM) a number of lipophilic compounds and electron transport inhibitors cause a partial and probably non-specific inhibition of the epoxidase [ 1, 121. In addition, the thiocarbamate antifungals, tolnaftate and tolciclate, which bear a superficial structural resemblance to naftifine, were found to be specific inhibitors of the fungal enzyme [14] . Some squalene analogues also inhibit the epoxidase in the micromolar range, as might be expected [ 11.
[lo].
Effects on mammalian squalene epoxidase
The rat liver microsomal squalene epoxidase has been extensively investigated [ 11 and the components of the system have been purified [ 111. The K , of the purified enzyme for squalene was 13 ,UM [ 113, which is similar to that of 11 ,UM measured in the microsomal system [5] . The rat liver microsomal epoxidase differs from the equivalent Canddu system in that it has an almost komplete requirement for the soluble cytoplasmic fraction, which can be satisfied by a combination of an anionic phospholipid and a protein termed Supernatant Protein Factor.
The effects of allylamines on mammalian squalene epoxidase have been examined in detail [S, 13, 151, especially in the case of terbinafine which is an orally active drug. Terbinafine proved to be a very weak reversible inhibitor of the rat liver microsomal enzyme with a K , of 77 ,UM, while the effect of naftifine is so weak as be regarded as nonspecific. Table 1 summarizes the activities of three allylamines against fungal and mammalian squalene epoxidases. This very high degree of selectivity is in agreement with findings in uivo that orally administered terbinafine has no significant effect on cholesterol biosynthesis in experimental animals or in humans. Inhibition of the rat liver epoxidase by terbinafine shows competitive kinetics with respect to the substrate squalene and also with respect to the soluble cytoplasmic fraction. Comparison of several mammalian liver squalene epoxidases showed the guinea pig enzyme to be particularly sensitive to allylamines (50% inhibition by about 5 an interaction with the substrate-binding site cannot be ruled out. A recently suggested model for inhibition [ 171 postulates that the high affinity of the allylamines for the fungal epoxidase may result from entropic binding of the molecule to two separate sites on the enzyme, namely the squalene-binding site (naphthalene ring) and an adjacent lipophilic pocket (side-chain). This model is compatible with the available evidence, and also with the more recent findings that naphthalene and 1 -methylnaphthalene are weak inhibitors of the epoxidase (5'0% inhibition at about 0.4 mM), while the terbinafine side-chain has no inhibitory effect at concentrations up to 1 mM. There is good evidence for a specific lipid-binding domain on squalene epoxidase, and the fungal and rat liver enzymes display quite different interactions with respect to detergents, phospholipids and fatty acids [ 11. Slight differences in alignment of the two binding sites could also provide the molecular basis for the selectivity of the allylamines, and the reversed selectivity of compounds such as NH-598. [13] . The precise mechanism of selectivity is
thus not yet clear but appears to reside in intrinsic differences in the respective epoxidase enzymes, as discussed in the following section. Very recently, the structure of the allylamine derivative NR-5'98 has been published [ 161. This interesting compound ( Fig. 1 ) with terbinafine-type side-chain and a strongly modified ring structure, is a potent inhibitor of mammalian squalene epoxidase but has no antifungal activity [ 161. This reversed selectivity also appears to operate at the enzymatic level.
Mechanism of epoxidase inhibition
Squalene epoxidation presents a complex target for inhibition, consisting of the terminal oxidase, a reductase supplying reducing equivalents from NAD(P)H, the lipid environment of the complex, and also (in the case of the liver epoxidases) soluble non-catalytic protein factors. In view of this complexity it is perhaps surprising that so few inhibitors of the system have been identified. In the case of the allylamines, inhibition has been clearly established to be at the level of the oxidase. Mechanism-based types of inhibition are ruled out by the reversible non-competitive non-time-dependent kinetics, and the allylamine nitrogen is clearly not required for inhibition. In view of their structure, kinetic properties and high selectivity, it is unlikely that the allylamines function simply as squalene analogues, but
Mechanism of the antifungal action of ally lamines
The potent inhibition of squalene epoxidase by allylamines described in the previous sections is reflected in a quantitatively similar inhibition of fungal ergosterol biosynthesis in both cell-free extracts and whole fungal cells. Epoxidase inhibition has been found to be an essential pre-requisite for antifungal activity within this class of compounds, although as mentioned previously, not all epoxidase inhibitors have antifungal activity. Extensive studies have shown that the squalene epoxidase is the only enzyme of the ergosterol pathway which is significantly inhibited by the allylamines, and that growth inhibition of various pathogenic fungi correlates with the sensitivity of cellular ergosterol biosynthesis [4, 6, 15'1. However, physiological factors which vary between different fungi also play an important role in determining the extent to which epoxidase inhibition is translated into actual growth-inhibitory action in a specific fungus. Filamentous growth is in general more susceptible to inhibition by this mechanism, and the evidence suggests that only partial inhibition of ergosterol biosynthesis is required for full suppression of growth in these fungi [ 6 ] . In C albicuns, which is dimorphic, the filamentous form is about ten-fold more susceptible than the yeast form to growth inhibition by allylamines while there is little difference between ergosterol biosynthesis inhibition in the two forms.
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cytochrome P-450-dependent, combine to make squalene epoxidase an attractive target for development of antifungal agents. 
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Inhibition of fungal squalene epoxidation leads to deficiency of ergosterol and accumulation of squalene in the cells, and both these events appear to play a role in blocking fungal growth. Since ergosterol is an essential component of the cell membrane, blocking its production would be expected to arrest growth. This results in a fungistatic action, as observed in C albicans and some other yeasts, and is comparable with the action of other ergosterol biosynthesis inhibitors such as the azoles. The accumulation of squalene is thought to be responsible for the fungicidal action against many fungi which is characteristic of the allylamines. As observed in a large number of studies in several pathogenic fungi, the onset of cell death always coincides with the accumulation of high levels of squalene, but not necessarily with ergosterol deficiency (Fig. 2) . The exact mechanism of induction of cell death is not clear but may involve disruption of membrane function and interference with cell wall biosynthesis.
The possibility of highly selective inhibition of fungal squalene epoxidase, the resultant primary fungicidal action, and the fact that the enzyme is not
